EUVIMEDEUVIMED entdecken
Crossref

Drug repurposing identifies candidate uterus-selective tocolytics for preterm labor

Shajila Siricilla iD, Christopher J Hansen iD, Jeremy Staub iD, Jordan Walker iD, Alexus J Brown iD, Sydney E Cole iD, Debasmita De, Lauren Hatcher, Carolyn Simpson, Jackson H Rogers iD, Naoko Boatwright iD, Stacey L Crockett iD und 9 weitere

Science Translational Medicine · 2026

DOI: 10.1126/scitranslmed.aeb2020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Shajila Siricilla und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Tocolytic Agents, Obstetric Labor, Premature, Drug Repositioning, Uterus. Die Arbeit nennt 105 Literaturangaben. Gefördert von: NICHD NIH HHS, NHLBI NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

At present, there are no US Food and Drug Administration (FDA)–approved tocolytics for the management of preterm labor. To identify drugs for repurposing as tocolytics, a phenotypic high-throughput screen against a library of 1191 FDA-approved drugs was performed for inhibitors of in vitro uterine myometrial contractions. A total of 51 drugs inhibited calcium (Ca 2+ ) mobilization in primary human myometrial cells. To minimize potential off-target effects, hit drugs were counterscreened against primary human aortic vascular smooth muscle cells, identifying 10 uterine-selective drugs. Of these, two drugs, the antiemetic fosaprepitant dimeglumine and the glucocorticoid ciclesonide, displayed favorable in vitro therapeutic indices (TIs > 5), inhibited contractions in human myometrial tissue ex vivo, and did not alter tone in the fetal murine ductus arteriosus ex vivo. Next, the potential synergy among hit drugs and clinically used tocolytics was evaluated using a high-throughput combination screen based on Ca 2+ mobilization in primary human myometrial cells. Four synergistic drug combinations incorporating ciclesonide, indomethacin, ivermectin, atosiban, or nelfinavir mesylate displayed favorable TIs of >5 and improved ex vivo tocolytic potency, efficacy, or both. Last, aprepitant, ciclesonide, and four synergistic drug combinations delayed delivery until term and improved neonatal viability and skin and lung maturation in a mouse model of induced preterm labor, with several combinations outperforming their component drugs. This approach established a systematic strategy for identifying uterus-selective tocolytics, and these findings support further preclinical development of repurposed drugs and drug combinations for the treatment of preterm labor to improve pregnancy and neonatal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tocolytic AgentsObstetric Labor, PrematureDrug RepositioningUterusFemaleHumansAnimalsPregnancyMyometriumCalciumMiceUterine ContractionDrug SynergismMyocytes, Smooth Muscle

Substanzen

Tocolytic AgentsCalcium

Autor:innen und Institutionen

  • Division of Neonatology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Department of Pharmacology, Vanderbilt University, Nashville, TN, USA.
  • Department of Biochemistry, Vanderbilt University, Nashville, TN, USA.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA.

ORCID-Profile: Shajila Siricilla, Christopher J Hansen, Jeremy Staub, Jordan Walker, Alexus J Brown, Sydney E Cole, Jackson H Rogers, Naoko Boatwright, Stacey L Crockett, Deanna C Sekulich, Christian T Meyer, Vito Quaranta, Quanhu Sheng, John T Benjamin, J M Newton, Bibhash C Paria, Jeff Reese, Jennifer L Herington

Förderung

  • NICHD NIH HHS
  • NHLBI NIH HHS
  • National Institute of Health

Zitieren

APA

Siricilla, S., Hansen, C. J., Staub, J., Walker, J., Brown, A. J., Cole, S. E., De, D., Hatcher, L., Simpson, C., Rogers, J. H., Boatwright, N., Crockett, S. L., Sekulich, D. C., Meyer, C. T., Quaranta, V., Sheng, Q., Benjamin, J. T., Newton, J. M., Paria, B. C., …, & Herington, J. L. (2026). Drug repurposing identifies candidate uterus-selective tocolytics for preterm labor. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aeb2020

Vancouver

Siricilla S, Hansen CJ, Staub J, Walker J, Brown AJ, Cole SE, et al. Drug repurposing identifies candidate uterus-selective tocolytics for preterm labor. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aeb2020

BibTeX
@article{Siricilla2026,
  author = {Siricilla, Shajila and Hansen, Christopher J and Staub, Jeremy and Walker, Jordan and Brown, Alexus J and Cole, Sydney E and De, Debasmita and Hatcher, Lauren and Simpson, Carolyn and Rogers, Jackson H and Boatwright, Naoko and Crockett, Stacey L and Sekulich, Deanna C and Meyer, Christian T and Quaranta, Vito and Sheng, Quanhu and Benjamin, John T and Newton, J M and Paria, Bibhash C and Reese, Jeff and Herington, Jennifer L},
  title = {Drug repurposing identifies candidate uterus-selective tocolytics for preterm labor},
  journal = {Science Translational Medicine},
  year = {2026},
  doi = {10.1126/scitranslmed.aeb2020}
}
Kostenlos starten →